TARNOW MICHAEL M 4
4 · Xenon Pharmaceuticals Inc. · Filed Nov 22, 2019
Insider Transaction Report
Form 4
TARNOW MICHAEL M
Director
Transactions
- Exercise/Conversion
Common Shares
2019-11-21$3.56/sh+5,144$18,313→ 69,713 total - Gift
Common Shares
2019-11-21−5,144→ 64,569 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-21−5,144→ 0 totalExercise: $3.56Exp: 2019-12-31→ Common Shares (5,144 underlying) - Exercise/Conversion
Common Shares
2019-11-21$3.51/sh+2,057$7,220→ 66,626 total - Gift
Common Shares
2019-11-21−2,057→ 64,569 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-21−2,057→ 0 totalExercise: $3.51Exp: 2020-06-30→ Common Shares (2,057 underlying)
Footnotes (4)
- [F1]The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
- [F2]The shares were gifted to family members that do not share the reporting person's household.
- [F3]The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.
- [F4]The shares subject to the option fully vested on June 30, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.